4.8 Review

The gut-bone axis: how bacterial metabolites bridge the distance

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 129, Issue 8, Pages 3018-3028

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI128521

Keywords

-

Funding

  1. NIH [DK1129461, DK108842, DK119229, RR028009, DK098391]
  2. Else Kroner-Fresenius-Stiftung
  3. Johannes und Frieda Marohn-Stiftung
  4. ELAN program of the Interdisciplinary Center for Clinical Research (IZKF) at the Friedrich-Alexander University Erlangen-Nurnberg
  5. Deutsche Forschungsgemeinschaft (German Research Foundation) [DFG-FOR2886 PANDORA-A01, DFG-CRC1181-B07]
  6. ERC Synergy Grant 4D Nanoscope

Ask authors/readers for more resources

The gut microbiome is a key regulator of bone health that affects postnatal skeletal development and skeletal involution. Alterations in microbiota composition and host responses to the microbiota contribute to pathological bone loss, while changes in microbiota composition that prevent, or reverse, bone loss may be achieved by nutritional supplements with prebiotics and probiotics. One mechanism whereby microbes influence organs of the body is through the production of metabolites that diffuse from the gut into the systemic circulation. Recently, short-chain fatty acids (SCFAs), which are generated by fermentation of complex carbohydrates, have emerged as key regulatory metabolites produced by the gut microbiota. This Review will focus on the effects of SCFAs on the musculoskeletal system and discuss the mechanisms whereby SCFAs regulate bone cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available